DuraSeal® as a spacer to reduce rectal doses in low-dose rate brachytherapy for prostate cancer - Abstract

The purpose of this study was to evaluate the utility of off-label use of DuraSeal® polyethylene glycol (PEG) gel in low-dose rate (LDR) prostate brachytherapy seed implantation to reduce rectal doses. Diluted DuraSeal® was easy to use and, in spite of a clearance effect, useful in decreasing D2cc rectal doses.

Written by:
Heikkilä VP, Kärnä A, Vaarala MH.   Are you the author?
Department of Radiotherapy, Oulu University Hospital, Finland; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Finland.  

Reference: Radiother Oncol. 2014 Sep 4. pii: S0167-8140(14)00334-X.
doi: 10.1016/j.radonc.2014.08.012


PubMed Abstract
PMID: 25201125

Go "Beyond the Abstract" - Read an article written by the authors for UroToday.com

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe